Yoshihiro Tamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yoshihiro Tamura has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Juichi Ito
Kyoto University
4 shared publications Hisanobu Tamaki
3 shared publicationsRyo Asato
3 shared publications- Shigeru Hirano
Department of Otolaryngology–Head and Neck Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
3 shared publications Hajime Nakamura
2 shared publicationsHideyuki Fukushima
2 shared publications
Latest Publications
- 1 January 2009
- Published by Taylor & Francis in Acta Oto-Laryngologica
- p. 1-10
In situ tissue engineering of canine skull with guided bone regeneration
- 1 January 2009
- Published by Taylor & Francis in Acta Oto-Laryngologica
- p. 1-10
In situ tissue engineering of canine skull with guided bone regeneration
- 1 January 2008
- Published by The Japan Laryngological Association in Koutou (The Larynx Japan)
- Vol. 20 (1) , 1-4
Study of the Potentiality of a Cell Culture Medium of Autologous Blood Serum for Cell Transplantation Therapy for Injured Vocal Folds
- 1 January 2008
- Published by The Japan Laryngological Association in Koutou (The Larynx Japan)
- Vol. 20 (1) , 1-4
Study of the Potentiality of a Cell Culture Medium of Autologous Blood Serum for Cell Transplantation Therapy for Injured Vocal Folds
- 1 January 2008
- Published by Japan Society for Head and Neck Cancer in Toukeibu Gan
- Vol. 34 (1) , 75-79
Outcomes of head and neck squamous cell carcinoma in the elderly
- 1 January 2008
- Published by Japan Society for Head and Neck Cancer in Toukeibu Gan
- Vol. 34 (1) , 75-79
Outcomes of head and neck squamous cell carcinoma in the elderly
- 1 January 2007
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 127 (sup557) , 62-65
Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years
It is important to prevent regional lymph node recurrence and distant metastasis to achieve better survival of laryngeal cancer. Therapeutic outcomes of 130 cases with laryngeal cancer treated at Kyoto University Hospital between 1995 and 2004 were reviewed. In all, 121 males and 9 females were involved. Their ages ranged from 40 years to 92 years (average 66 years). All tumors were squamous cell carcinoma - arising at the glottis in 111 cases, the supraglottis in 18, and the subglottis in 1 case. Most glottic cancers (77.5%) were classified as stage I or II, while most supraglottic cancers (77.8%) were at stage III or IV. Stage I/II cancers were basically treated by conventional radiotherapy (60-66 Gy) and twice-daily hyperfractionated radiotherapy (70-74 Gy), respectively, attempting to preserve the larynx. Total laryngectomy with neck dissection was performed in the treatment of stage III/IV cases. Five-year disease-specific survival rates were 100%, 96%, 100%, and 68% for stage I, II, III, and IV, respectively. Five-year laryngeal preservation rates were 98%, 100%, 86%, 0%, and 0% for T1a, T1b, T2, T3, and T4 of glottic cancer, respectively. Local recurrence occurred in five cases of stage I/II glottic cancer, which was successfully salvaged. Regional lymph node recurrence occurred in five cases including four patients with glottic cancer and one with supraglottic cancer. Two of them died of disease despite undergoing salvage therapy. Distant metastasis occurred in the lung in four cases including one glottic and three supraglottic cancer patients after initial treatment.
- 1 January 2007
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 127 (sup557) , 62-65
Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years
It is important to prevent regional lymph node recurrence and distant metastasis to achieve better survival of laryngeal cancer. Therapeutic outcomes of 130 cases with laryngeal cancer treated at Kyoto University Hospital between 1995 and 2004 were reviewed. In all, 121 males and 9 females were involved. Their ages ranged from 40 years to 92 years (average 66 years). All tumors were squamous cell carcinoma - arising at the glottis in 111 cases, the supraglottis in 18, and the subglottis in 1 case. Most glottic cancers (77.5%) were classified as stage I or II, while most supraglottic cancers (77.8%) were at stage III or IV. Stage I/II cancers were basically treated by conventional radiotherapy (60-66 Gy) and twice-daily hyperfractionated radiotherapy (70-74 Gy), respectively, attempting to preserve the larynx. Total laryngectomy with neck dissection was performed in the treatment of stage III/IV cases. Five-year disease-specific survival rates were 100%, 96%, 100%, and 68% for stage I, II, III, and IV, respectively. Five-year laryngeal preservation rates were 98%, 100%, 86%, 0%, and 0% for T1a, T1b, T2, T3, and T4 of glottic cancer, respectively. Local recurrence occurred in five cases of stage I/II glottic cancer, which was successfully salvaged. Regional lymph node recurrence occurred in five cases including four patients with glottic cancer and one with supraglottic cancer. Two of them died of disease despite undergoing salvage therapy. Distant metastasis occurred in the lung in four cases including one glottic and three supraglottic cancer patients after initial treatment.
- 1 January 2006
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 99 (2) , 105-110
Maxillary Cancer which Caused Marked Systemic Inflammatory Reaction
- 1 January 2006
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 99 (2) , 105-110
Maxillary Cancer which Caused Marked Systemic Inflammatory Reaction
- 1 January 1997
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 90 (6) , 633-639
Prognosis of Severe Idiopathic Sudden Sensorineural Hearing Loss and Vertigo in Interferon Therapy.
- 1 January 1997
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 90 (6) , 633-639
Prognosis of Severe Idiopathic Sudden Sensorineural Hearing Loss and Vertigo in Interferon Therapy.
- 1 January 1996
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 89 (8) , 1027-1030
Control of Postoperative Pain with Beriplast P in Tonsillectomy.
- 1 January 1996
- Published by The Society of Practical Otolaryngology in Practica Oto-Rhino-Laryngologica
- Vol. 89 (8) , 1027-1030
Control of Postoperative Pain with Beriplast P in Tonsillectomy.